stars 1 stars 2 stars 3

Pre-Cure is transforming cancer treatment selection through a predictive, biopsy-based 3D functional platform. By evaluating each patient’s individual tumor response, our drug-prioritization test identifies the therapies most likely to be effective and supports the selection of the right treatment from the very first line. Pre-Cure aims to improve patient outcomes while reducing ineffective treatment cycles.

Pre-Cure Questions

Dan Simhon is the Co-founder and CEO of Pre-Cure.

6 people are employed at Pre-Cure.

Top Pre-Cure Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users